Volume 11, Number 8—August 2005
Research
Spoligotyping and Mycobacterium tuberculosis
Andrea Gori*
, Alessandra Bandera*, Giulia Marchetti*, Anna Degli Esposti*, Lidia Catozzi*, Gian Piero Nardi*, Lidia Gazzola*, Giulio Ferrario*, Jan D.A. van Embden†, Dick van Soolingen†, Mauro Moroni*, and Fabio Franzetti*
, Alessandra Bandera*, Giulia Marchetti*, Anna Degli Esposti*, Lidia Catozzi*, Gian Piero Nardi*, Lidia Gazzola*, Giulio Ferrario*, Jan D.A. van Embden†, Dick van Soolingen†, Mauro Moroni*, and Fabio Franzetti*Table 1
Characteristics of 148 patients with acid-fast bacilli in biologic specimens*
| Age, y | |
|---|---|
| Median (range) | 34 (3–88) |
| Mean | 39.3 |
| Sex, no. (%) | |
| Male | 105 (70.9) |
| Female | 43 (29.1) |
| Type of patient, no. (%) | |
| Infectious diseases | 124 (83.8) |
| Pneumology | 10 (6.8) |
| Internal medicine | 10 (6.8) |
| Other | 4 (2.7) |
| HIV status, no. (%) | |
| Negative | 52 (35.1) |
| Positive | 96 (64.9) |
| CD4+ cell count/μL† | |
| Median | 47.5 |
| Mean (range) | 105 (1–589) |
| Previous tuberculosis, no. (%) | 20 (13.5) |
| Previous MAC infection, no. (%) |
10 (6.8) |
| No tuberculosis or MAC infection, no. (%) | 118 (79.7) |
*MAC, Mycobacterium avium complex.
†Data available for 90 of 96 HIV-infected patients.
